SCIENTIFIC HUB

Follow the evidence.

189.272 articles found

Source record

Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitors.

Axten JM, Ding X, Stasi LP, Zhao B, Sang Y, Ho MH, Wang L, Zhang M, Guo X, Tan C, Feng X, Edge C, Valko K, Li Y, Dong K, Guan X, Zinn N, David Tattersall F, Ren F, Su DS, Reith AD.

RSC Med Chem · 2025-11-17

DOI: 10.1039/d5md00856ePMID: 41393202

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression.

Coughlin DG, Jain L, Khrestian M, Bozoki AC, Galvin JE, Irwin DJ, Lippa CF, Litvan I, Pillai JA, Tousi B, Lopez OL, Berman S, Tsuang DW, Zabetian CP, Fleisher JE, Taylor AS, Leverenz JB, Bekris LM, Galasko D, Dementia With Lewy Bodies Consortium.

Neurology · 2025-11-17

DOI: 10.1212/wnl.0000000000214346PMID: 41248454

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Integrating [<sup>11</sup>C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration.

Mondragon JD, Marcolini S, Giacobbo BL, Elsinga PH, Dierckx RAJO, Tollenaere M, van Dam D, De Deyn PP.

Nucl Med Biol · 2025-11-17

DOI: 10.1016/j.nucmedbio.2025.109581PMID: 41297218

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.